Implementation of Diabetes Mellitus Program in the Tyumen region
Aim. To assess results of realization of the regional Diabetes Mellitus Program in the Tyumen region. Materials and methods. Materials of the regional Diabetes Mellitus Registry for 1999-2007 were analysed. Results. DM1 and DM2 morbidity increased from 6.6 to 8.16 and from 97.3 to 216.96 per100,0...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2009-03-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/5418 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850141185480327168 |
|---|---|
| author | Lyudmila Alexandrovna Suplotova L N Belchikova N S Brynza |
| author_facet | Lyudmila Alexandrovna Suplotova L N Belchikova N S Brynza |
| author_sort | Lyudmila Alexandrovna Suplotova |
| collection | DOAJ |
| description | Aim. To assess results of realization of the regional Diabetes Mellitus Program in the Tyumen region. Materials and methods. Materials of the regional Diabetes Mellitus Registry for 1999-2007 were analysed. Results. DM1 and DM2 morbidity increased from 6.6 to 8.16 and from 97.3 to 216.96 per100,000 population respectively. Primary disability rate among DM1 and DM2 patientsdecreased by a factor of 2. The fraction of patients with severe diabetic complications also decreased (1.3 times for blindness, 1.8 times for amputations). The frequency of diabeticcoma decreased by a factor of 2. Thirty five Diabetes School were organized. Mean life expectancy of DM1 and DM2 subjects increased from 49.55?5.43 to 50.11?2.96 years(p = 0.0001) and from 68.00?1.79 to 71.52?0.39 years (r = 0.0001) respectively. Mortality rate in DM1 and DM2 patients dropped by a factor of 5 and 3. All DM patients use onlymodern insulin formulations, with analogs accounting for 39.5% and human recombinant insulins for the rest of the total. Therapeutic use of secretagogues for the managementof DM2 decreased from 84.8 to 49.1% (p = 0.0001) and that of metformin increased form 6.8 to 28% (p = 0.0001); the need in insulin therapy also increased. Conclusion. Elaboration and implementation of the program contributed to the decreased occurrence of diabetic coma, blindness, and amputations in DM1 and DM2 patients,their longer life expectancy, and improved availability of high-quality oral hypoglycemic agents. |
| format | Article |
| id | doaj-art-bb910a1413bd4c57879ef0c8c29bdc77 |
| institution | OA Journals |
| issn | 2072-0351 2072-0378 |
| language | English |
| publishDate | 2009-03-01 |
| publisher | Endocrinology Research Centre |
| record_format | Article |
| series | Сахарный диабет |
| spelling | doaj-art-bb910a1413bd4c57879ef0c8c29bdc772025-08-20T02:29:31ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782009-03-01121333510.14341/2072-0351-54185376Implementation of Diabetes Mellitus Program in the Tyumen regionLyudmila Alexandrovna Suplotova0L N Belchikova1N S Brynza2ГОУ ВПО ТюмГМА Росздрава, Тюмень; ГЛПУ «Тюменская областная клиническая больница», ТюменьГОУ ВПО ТюмГМА Росздрава, Тюмень; ГЛПУ «Тюменская областная клиническая больница», ТюменьГОУ ВПО ТюмГМА Росздрава, Тюмень; ГЛПУ «Тюменская областная клиническая больница», ТюменьAim. To assess results of realization of the regional Diabetes Mellitus Program in the Tyumen region. Materials and methods. Materials of the regional Diabetes Mellitus Registry for 1999-2007 were analysed. Results. DM1 and DM2 morbidity increased from 6.6 to 8.16 and from 97.3 to 216.96 per100,000 population respectively. Primary disability rate among DM1 and DM2 patientsdecreased by a factor of 2. The fraction of patients with severe diabetic complications also decreased (1.3 times for blindness, 1.8 times for amputations). The frequency of diabeticcoma decreased by a factor of 2. Thirty five Diabetes School were organized. Mean life expectancy of DM1 and DM2 subjects increased from 49.55?5.43 to 50.11?2.96 years(p = 0.0001) and from 68.00?1.79 to 71.52?0.39 years (r = 0.0001) respectively. Mortality rate in DM1 and DM2 patients dropped by a factor of 5 and 3. All DM patients use onlymodern insulin formulations, with analogs accounting for 39.5% and human recombinant insulins for the rest of the total. Therapeutic use of secretagogues for the managementof DM2 decreased from 84.8 to 49.1% (p = 0.0001) and that of metformin increased form 6.8 to 28% (p = 0.0001); the need in insulin therapy also increased. Conclusion. Elaboration and implementation of the program contributed to the decreased occurrence of diabetic coma, blindness, and amputations in DM1 and DM2 patients,their longer life expectancy, and improved availability of high-quality oral hypoglycemic agents.https://www.dia-endojournals.ru/jour/article/view/5418diabetes mellitusregional registrymorbiditydisabilitycomplicationsmortality |
| spellingShingle | Lyudmila Alexandrovna Suplotova L N Belchikova N S Brynza Implementation of Diabetes Mellitus Program in the Tyumen region Сахарный диабет diabetes mellitus regional registry morbidity disability complications mortality |
| title | Implementation of Diabetes Mellitus Program in the Tyumen region |
| title_full | Implementation of Diabetes Mellitus Program in the Tyumen region |
| title_fullStr | Implementation of Diabetes Mellitus Program in the Tyumen region |
| title_full_unstemmed | Implementation of Diabetes Mellitus Program in the Tyumen region |
| title_short | Implementation of Diabetes Mellitus Program in the Tyumen region |
| title_sort | implementation of diabetes mellitus program in the tyumen region |
| topic | diabetes mellitus regional registry morbidity disability complications mortality |
| url | https://www.dia-endojournals.ru/jour/article/view/5418 |
| work_keys_str_mv | AT lyudmilaalexandrovnasuplotova implementationofdiabetesmellitusprograminthetyumenregion AT lnbelchikova implementationofdiabetesmellitusprograminthetyumenregion AT nsbrynza implementationofdiabetesmellitusprograminthetyumenregion |